← Back to Search

OCM-RISE Implementation for Opioid Use Disorder

N/A
Waitlist Available
Led By Edward Nunes, MD
Research Sponsored by New York State Psychiatric Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 30 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is designed to study how to best implement a new court model - the opioid court model - across New York State in order to reduce overdose, opioid use disorder, and recidivism.

Who is the study for?
This trial is for adults over the age of 18 who are employed at substance use treatment agencies or by the Unified Court System/County Court in participating counties. Participants must understand and speak English. There are no specific exclusion criteria listed, meaning a wide range of individuals involved in these systems may participate.
What is being tested?
The OCM-RISE intervention is being tested to improve the opioid court model (OCM) across New York State. The goal is to address opioid use disorder (OUD), reduce overdoses, and lower recidivism by refining rapid screening processes and linking individuals to medication-assisted treatments more effectively.
What are the potential side effects?
Since this trial focuses on implementing a system-level intervention rather than testing a medical drug, it does not have traditional side effects. However, there could be indirect impacts on staff workload or resource allocation within participating institutions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 30 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 30 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants who are abstinent from opioid use
Number of participants who are retained in treatment for at least 60 days
Number of participants who graduate from court
+1 more
Secondary study objectives
Acceptability of the opioid court
Adoption of OCM RISE
Number of court participants who are provided medication for Opioid Use Disorder (MOUD) Initiation
+3 more
Other study objectives
Defendant Characteristics
Inter-agency Organizational Features
Knowledge, Attitudes towards MOUD
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: OCM-RISEExperimental Treatment1 Intervention
Opioid court team provided external facilitation to generate action plans to develop and roll out or improve practice of the county opioid court.

Find a Location

Who is running the clinical trial?

National Institute of Drug AbuseFED
9 Previous Clinical Trials
9,079 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,586 Previous Clinical Trials
3,325,090 Total Patients Enrolled
New York State Psychiatric InstituteLead Sponsor
478 Previous Clinical Trials
150,533 Total Patients Enrolled
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top